Dr Igor Gonda, has over 40 years of experience in the research and development of inhaled therapies in academia and industry in Australia, UK and USA. He is the Founder and CEO of Respidex, a San Francisco-based consulting company providing technical and regulatory advice. Dr Gonda has held a variety of executive positions in US and Australian pharmaceutical and biotech companies.


His research focus has been primarily in the area of drugs and biologics administered to the lung and nose, with research conducted in both industry and universities in England, Australia and the US. He is a Director of Inspiring Holdings Pty Ltd and the Chair of its SAB.